Neuromodulation therapy for atrial fibrillation
- PMID: 35988908
- PMCID: PMC10224761
- DOI: 10.1016/j.hrthm.2022.08.011
Neuromodulation therapy for atrial fibrillation
Abstract
Atrial fibrillation has a multifactorial pathophysiology influenced by cardiac autonomic innervation. Both sympathetic and parasympathetic influences are profibrillatory. Innovative therapies targeting the neurocardiac axis include catheter ablation or pharmacologic suppression of ganglionated plexi, renal sympathetic denervation, low-level vagal stimulation, and stellate ganglion blockade. To date, these therapies have variable efficacy. As our understanding of atrial fibrillation and the cardiac nervous system expands, our approach to therapeutic neuromodulation will continue evolving for the benefit of those with AF.
Keywords: Atrial fibrillation; Autonomics; Ganglionated plexi; Neurocardiac axis; Neuromodulation.
Copyright © 2022 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Is the Atrial Neural Plexis a Therapeutic Target in Atrial Fibrillation?Methodist Debakey Cardiovasc J. 2015 Apr-Jun;11(2):82-6. doi: 10.14797/mdcj-11-2-82. Methodist Debakey Cardiovasc J. 2015. PMID: 26306124 Free PMC article. Review.
-
Ganglionated plexi as neuromodulation targets for atrial fibrillation.J Cardiovasc Electrophysiol. 2017 Dec;28(12):1485-1491. doi: 10.1111/jce.13319. Epub 2017 Sep 8. J Cardiovasc Electrophysiol. 2017. PMID: 28833764 Free PMC article. Review.
-
Atrial autonomic innervation: a target for interventional antiarrhythmic therapy?J Am Coll Cardiol. 2014 Jan 28;63(3):215-24. doi: 10.1016/j.jacc.2013.09.020. Epub 2013 Oct 16. J Am Coll Cardiol. 2014. PMID: 24140663 Review.
-
Neural Mechanisms and Therapeutic Opportunities for Atrial Fibrillation.Methodist Debakey Cardiovasc J. 2021 Apr 5;17(1):43-47. doi: 10.14797/FVDN2224. Epub 2021 Mar 25. Methodist Debakey Cardiovasc J. 2021. PMID: 34104319 Free PMC article. Review.
-
Neuromodulation for cardiac arrhythmia.Heart Rhythm. 2016 Feb;13(2):584-92. doi: 10.1016/j.hrthm.2015.10.001. Epub 2015 Oct 9. Heart Rhythm. 2016. PMID: 26440550 Review.
Cited by
-
Emerging Role of Renal Sympathetic Denervation as an Adjunct Therapy to Atrial Fibrillation Ablation.Rev Cardiovasc Med. 2024 Mar 28;25(4):122. doi: 10.31083/j.rcm2504122. eCollection 2024 Apr. Rev Cardiovasc Med. 2024. PMID: 39076548 Free PMC article. Review.
-
Integrated Management of Persistent Atrial Fibrillation.Biomedicines. 2025 Jan 2;13(1):91. doi: 10.3390/biomedicines13010091. Biomedicines. 2025. PMID: 39857675 Free PMC article. Review.
-
Catheter Ablation in Atrial Fibrillation: Recent Advances.J Clin Med. 2024 Dec 17;13(24):7700. doi: 10.3390/jcm13247700. J Clin Med. 2024. PMID: 39768622 Free PMC article. Review.
-
"Pharmacological" analysis of atrial fibrillation maintenance mechanism: reentry, wavelets, or focal?Front Cardiovasc Med. 2025 Jan 24;12:1447542. doi: 10.3389/fcvm.2025.1447542. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 39925977 Free PMC article. Review.
-
Development of neuromodulation for atrial fibrillation: a narrative review.J Thorac Dis. 2024 May 31;16(5):3472-3483. doi: 10.21037/jtd-23-1981. Epub 2024 May 20. J Thorac Dis. 2024. PMID: 38883655 Free PMC article. Review.
References
-
- Bhatt HV, Fischer GW. Atrial Fibrillation: Pathophysiology and Therapeutic Options. J Cardiothorac Vasc Anesth 2015;29:1333–1340. - PubMed
-
- de Vos CB, Nieuwlaat R, Crijns HJGM, et al. Autonomic trigger patterns and anti-arrhythmic treatment of paroxysmal atrial fibrillation. EHJ 2008;29:632–639. - PubMed
-
- January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. JACC 2014;64:e1–e76. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials